This is a test version of Biostars. For the public version, visit https://www.biostars.org.
What's your preferred pathway enrichment analysis tool after DEG analysis and why?

So firstly, I'm completely aware that this type of question has been asked multiple times (I know this since I've been scrolling over these type of questions for the past 2 days), but I'm actually more interested in knowing the reasons as to why some people prefer

I've performed differential expression analysis using DESeq2 and I want to see which Gene ontology terms, KEGG pathway terms etc are enriched in my data set. I've initially tried using clusterProfileR, but I keep getting 3 enriched terms for all my differentially expressed genes using enrichGO(). I also know that some input in clusterProfileR requires you to put logFC values, so I wasn't sure if that was for ALL the genes analysed, or just the differentially expressed genes.

I've also used goseq but my main issue with that is the GO terms are too broad.

I also only have about 300 DEGs, so I'm not really sure if this sort of analysis is best performed when you have a myriad of DEGs, or can be done with a small number.

Anyway, looking forward to hearing people's responses :)

gene ontology rna-seq

Check out our GO_MWU: great power, no need to spit the data into DEGs / non-DEGs (the test is ranks-based so it can use any measure according to which the genes can be ranked), intuitive graphical representation of results. https://github.com/z0on/GO_MWU - Misha

4 answers

I'm a big user of GOseq, which allows to control for the fact that longer and more highly expressed genes are more likely to be found to be differential, if long or highly expressed genes are not evenly distributed between pathways/categories, then this can bias your enriched pathways.

I also like the GSEA-like algorithms, because you do not have to set an artificial limit on what you consider significant. The version of this where you rank on significance suffers from the same gene-length bias that traditional GO tests suffer, but this may be lessened by ranking on some suitably strunken logFC metric. cameraPR from limma is a good example of this.

Finally we've used SPIA before, which is a pathway enrichment tool that takes the topology of the network into account. Its a great idea, let down by the quality of the pathway annotations it runs on.

The version of this where you rank on significance suffers from the same gene-length bias that traditional GO tests suffer, but this may be lessened by ranking on some suitably strunken logFC metric. cameraPR from limma is a good example of this.

Could you expand on this? It seems that in general, camera and cameraPR get used with the limma moderated-t statistic.

For anyone else confused about shrinkage of logFC, see Gordon Smith's reply to this question regarding how logFC is shrunk towards zero by limma etc.

Indeed, most people use camera and cameraPR with t. But I think this would still suffer from length bias. You could use the shrunken LFCs that come out of DESeq2. However, there was recently a paper suggesting that even this still suffers from length bias.

Essentially every free tool is using the same set of databases and quite similar algorithms (there's a smallish set to choose from with a few tweaks here and there), so it's unsurprising that you get similar results regardless of which tool you use. To be frank, if you want different results you need to use a different database. We're pretty happy with IPA in this regard. It can be rather pricey, but if you can go in with multiple labs on a license then it becomes more feasible.

I use Gene Set Clustering based on Functional annotation (GeneSCF)

Log in to answer this question.